RxDoctor Payments DataLook up a doctor →

Amar Majjhoo, MD

Rheumatology · Saint Clair Shores, MINPI 1255411039

Payments from drug & device makers

$9,052,847in general payments, 2019–2025

Across 3,581 payments — averaging $2528.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$7.4M
  • AbbVie$359K
  • Johnson & Johnson$222K
  • Janssen Research & Development, LLC$191K
  • Janssen Scientific Affairs, LLC$158K
  • Bristol Myers Squibb$125K
  • plus $554K from 47 others
$7,122in research payments, 2019–2025

Across 3 payments — averaging $2373.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$4K
  • Novartis$3K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,052,847 in reported general payments places this provider in the 95th percentile of 195 rheumatology providers in Michigan.

See all rheumatology providers in Michigan

Medicare billing

Part B allowed, 2024
$3,447,847
Medicare patients
431
Services billed
246,947

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Saint Clair Shores

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →